These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9844723)

  • 1. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation.
    Azari M; Ebeling A; Baker R; Burhop K; Camacho T; Estep T; Guzder S; Marshall T; Rohn K; Sarajari R
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):577-82. PubMed ID: 9844723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation--effect of crosslinking.
    Azari M; Catarello J; Burhop K; Camacho T; Ebeling A; Estep T; Guzder S; Krause K; Marshall T; Rohn K; Sarajari R; Boose JA; Gauvin G; Horner R; Lu B; Pearson L; Vacante D
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Nov; 25(6):521-6. PubMed ID: 9352057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
    Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
    Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin.
    Farmer M; Ebeling A; Marshall T; Hauck W; Sun CS; White E; Long Z
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):429-33. PubMed ID: 1327242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
    Borovec S; Broumis C; Adcock W; Fang R; Uren E
    Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial.
    Schubert A; Przybelski RJ; Eidt JF; Lasky LC; Marks KE; Karafa M; Novick AC; O'Hara JF; Saunders ME; Blue JW; Tetzlaff JE; Mascha E;
    Anesth Analg; 2003 Aug; 97(2):323-332. PubMed ID: 12873912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    J Med Virol; 1996 May; 49(1):1-6. PubMed ID: 8732864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
    Morrica A; Nardini C; Falbo A; Bailey AC; Bucci E
    Biologicals; 2003 Sep; 31(3):165-73. PubMed ID: 12935804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diaspirin crosslinked hemoglobin (DCLHb): characterization of the process and the product manufactured under GMP requirements for clinical studies.
    Azari M; Rohn K; Picken J
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):701-8. PubMed ID: 7994391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin.
    Caruso C; Gobbi E; Biosa T; Andra' M; Cavallazzi U; Masoero L
    J Virol Methods; 2014 Nov; 208():79-84. PubMed ID: 25110118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of polymerized, diaspirin cross-linked hemoglobins.
    Nelson D; Hai T; Srnak A; Ebeling A; Kunas G; Catarello J; Burhop K
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):253-8. PubMed ID: 1391439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.
    Omar A; Kempf C; Immelmann A; Rentsch M; Morgenthaler JJ
    Transfusion; 1996 Oct; 36(10):866-72. PubMed ID: 8863772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group.
    Lamy ML; Daily EK; Brichant JF; Larbuisson RP; Demeyere RH; Vandermeersch EA; Lehot JJ; Parsloe MR; Berridge JC; Sinclair CJ; Baron JF; Przybelski RJ
    Anesthesiology; 2000 Mar; 92(3):646-56. PubMed ID: 10719942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis.
    Habler O; Kleen M; Pape A; Meisner F; Kemming G; Messmer K
    Crit Care Med; 2000 Jun; 28(6):1889-98. PubMed ID: 10890638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resuscitation with increasing doses of diaspirin crosslinked hemoglobin in swine.
    Marchand G; Dunlap E; Farrell L; Nigro C; Burhop K
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Sep; 24(5):469-87. PubMed ID: 8879422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaspirin crosslinked hemoglobin (DCLHb): bioanalytical studies in swine.
    Bush S; Marshall T; Spicuzza J; Nelson D
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):917-22. PubMed ID: 7994418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke.
    Saxena R; Wijnhoud AD; Carton H; Hacke W; Kaste M; Przybelski RJ; Stern KN; Koudstaal PJ
    Stroke; 1999 May; 30(5):993-6. PubMed ID: 10229733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diaspirin crosslinked hemoglobin (DCLHb) polymerization.
    Hai TT; Nelson D; Pereira D; Srnak A
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):923-31. PubMed ID: 7994419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus safety of a porcine-derived medical device: evaluation of a viral inactivation method.
    Hodde J; Hiles M
    Biotechnol Bioeng; 2002 Jul; 79(2):211-6. PubMed ID: 12115437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Diaspirin Crosslinked Hemoglobin (DCLHb) on microcirculation and local tissue pO2 of striated skin muscle following resuscitation from hemorrhagic shock.
    Hungerer S; Nolte D; Botzlar A; Messmer K
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(5):455-71. PubMed ID: 16893810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.